Balicatib, also known as AAE581, is an inhibitor of the osteoclastic enzyme cathepsin K. Balicatib partially prevented ovariectomy-induced changes in bone mass, inhibited bone turnover at most sites, and had an unexpected stimulatory effect on periosteal bone formation.
Cysteine Protease Inhibitors Related Prodcuts:
Odanacatib; E-64; PMSF; Pepstatin A; Leupeptin hemisulfate; Aloxistatin